2026-10-13T08:28:50Z https://api.figshare.com/v2/oai

oai:figshare.com:article/34029579 2026-09-30T04:42:25Z category_388 portal_316 item_type_3 month_year_09_2026

Supplementary file 1_A novel multimodal model integrating CT-based deep learning and clinical information for predicting 1-year OS of first-line immunotherapy in ES-SCLC patients.docx Jing Zhang (23775) Liwen Gu (14555828) Peixin Dong (3919886) Yu Hu (126677) Baomo Liu (3619250) Zhihua Wen (2550997) Yanbin Zhou (184392) Haohua Yao (668960) Oncology and Carcinogenesis not elsewhere classified bone metastasis deep learning extensive stage small-cell lung cancer immunotherapy pro-gastrin-releasing peptide Background<p>Extensive-stage small cell lung cancer (ES-SCLC) is a rare yet highly aggressive malignancy with severely limited treatment options. The efficacy of immunotherapy for ES-SCLC remain limited, with only 14% of patients deriving additional benefit from immune checkpoint inhibitors (ICIs), underscoring significant heterogeneity in patient response. This study aimed to develop a model for the accurate prediction of prognosis and therapeutic response to optimize treatment strategies.</p>Methods<p>99 and 25 ES-SCLC patients were enrolled as training and independent internal validation cohorts. Baseline CT images, clinical data, and laboratory markers were collected. Prognostic factors were screened via Cox regression. A mediastinal window CT-based deep learning model (MWDL) was developed and combined with Progastrin-releasing peptide (log(ProGRP + 1)) and bone metastasis to establish the novel MWGB-Cox model.</p>Results<p>ProGRP and bone metastasis were independent prognostic factors with area under the curves (AUCs) of 0.705 and 0.666 respectively for predicting 1-year OS. Among the pure deep learning models, the MWDL model achieved better performance with a mean AUC of 0.813 than the deep learning model based on lung window CT images (LWDL, AUC 0.756). Whereas the multimodal MWGB-Cox model not only achieved the highest AUC (0.902) for 1-year OS prediction, but also effectively overcame the limitation of insufficient sensitivity. The predictive performance of the MWGB-Cox model was further validated in the independent internal validation cohort.</p>Conclusions<p>This novel, simple, and cost-effective multimodal MWGB-Cox model integrating CT-based deep learning, log(ProGRP + 1), and bone metastasis could robustly predict 1-year OS of ES-SCLC patients receiving first-line immunotherapy, providing a reliable tool for clinical decision-making.</p>Significance<p>By integrating CT-based deep learning, log(ProGRP + 1) levels, and bone metastasis, the novel multimodal model achieved the highest predictive AUC (0.902) with improved sensitivity, serving as a simple, cost-effective tool for clinical decision-making.</p> 2026-09-30T04:42:25Z Dataset Dataset 10.3389/fonc.2026.1901931.s001 https://figshare.com/articles/dataset/Supplementary_file_1_A_novel_multimodal_model_integrating_CT-based_deep_learning_and_clinical_information_for_predicting_1-year_OS_of_first-line_immunotherapy_in_ES-SCLC_patients_docx/34029579 CC BY 4.0